SCHEMBL10323315

SCHEMBL10323315

CC(C)(C)OC(=O)N(c1cccc(CN(Cc2ccc(N(c3ccccc3)c3ccccc3)cc2)S(=O)(=O)c2cccnc2)n1)C(C(=O)O)C(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL534321 0.93 PTGER2 (0.59) PTGER2
SCHEMBL533796 0.91 PTGER2 (0.56) PTGER2
SCHEMBL10322181 0.90 PTGER2 (0.54) PTGER2
SCHEMBL533600 0.89 PTGER2 (0.63) PTGER2
SCHEMBL533713 0.89 PTGER2 (0.61) PTGER2
SCHEMBL11024695 0.89 PTGER2 (0.61) PTGER2
SCHEMBL534193 0.88 PTGER2 (0.62) PTGER2
SCHEMBL13571749 0.88 PTGER2 (0.63) PTGER2
SCHEMBL17472615 0.87 PTGER2 (0.68) PTGER2
SCHEMBL11024446 0.87 PTGER2 (0.63) PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184747-A1 ANILINE COMPOUND UBE INDUSTRIES, LTD. (JP) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184747-A1 ANILINE COMPOUND PTGER2, ADRB2, PTGER1 PTGER2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.